Notwithstanding several setbacks, a number of MDM2 inhibitors have now progressed into late-stage medical advancement. New tactics have also been made to enhance the efficacy of MDM2 inhibitors and also to mitigate their on-concentrate on toxicity. In this evaluation, we summarize the development and problems in the event of the MDM2 specific thera